2004
DOI: 10.1002/bies.10386
|View full text |Cite
|
Sign up to set email alerts
|

Recombination in HIV and the evolution of drug resistance: for better or for worse?

Abstract: The rapid evolution of drug resistance remains a major obstacle for HIV therapy. The capacity of the virus for recombination is widely believed to facilitate the evolution of drug resistance. Here, we challenge this intuitive view. We develop a population genetic model of HIV replication that incorporates the processes of mutation, cellular superinfection, and recombination. We show that cellular superinfection increases the abundance of low fitness viruses at the expense of the fittest strains due to the mixi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
114
1

Year Published

2004
2004
2019
2019

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(120 citation statements)
references
References 41 publications
5
114
1
Order By: Relevance
“…Recombination represents a complementary mechanism that has the potential to accelerate HIV-1 diversification and evolution greatly (30,31), although some models challenge this view (32,33). By introducing multiple simultaneous alterations in the genome, recombination can generate constellations of alleles that would be otherwise unlikely or unable to assemble by means of mutation alone (31,34).…”
Section: Discussionmentioning
confidence: 99%
“…Recombination represents a complementary mechanism that has the potential to accelerate HIV-1 diversification and evolution greatly (30,31), although some models challenge this view (32,33). By introducing multiple simultaneous alterations in the genome, recombination can generate constellations of alleles that would be otherwise unlikely or unable to assemble by means of mutation alone (31,34).…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, the effect of recombination on the evolution of drug resistance has attracted considerable attention from epidemiologists, in particular with respect to resistance in the human immunodeficiency virus (HIV) (Bretscher et al 2004;Fraser 2005;Carvajal-Rodríguez et al 2007;Kouyos et al 2009). However, most epidemiological models are deterministic and focus on the time to resistance rather than on the probability of resistance (Bretscher et al 2004;Fraser 2005). An exception is the simulation study by Kouyos et al (2009), which incorporates stochasticity and allows populations to go extinct.…”
mentioning
confidence: 99%
“…In a recent study aimed at understanding the kinetics of HIV recombination, Bretscher et al (15) considered a framework where cells are either singly or doubly infected by HIV. This framework provides useful insights into HIV recombination, challenging the widespread notion that recombination facilitates the emergence of drug resistance.…”
mentioning
confidence: 99%